ACB Key Statistics, Chart & Performance
The current stock price of ACB is 4.54 USD. In the past year, price increased by 1.11%.
ACB Latest News, Press Relases and Analysis
ACB Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 47 | 977.11B | ||
| JNJ | JOHNSON & JOHNSON | 19.78 | 494.70B | ||
| MRK | MERCK & CO. INC. | 11.61 | 253.84B | ||
| PFE | PFIZER INC | 7.99 | 145.38B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.77 | 103.74B | ||
| ZTS | ZOETIS INC | 19.33 | 54.02B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.64 | 22.86B | ||
| VTRS | VIATRIS INC | 4.65 | 12.49B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.1 | 11.02B | ||
| CORT | CORCEPT THERAPEUTICS INC | 95.08 | 8.80B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 7.45B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.30B |
Related stock screener links
About ACB
Company Profile
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
Company Info
AURORA CANNABIS INC
2207 90B Street Sw
Leduc ALBERTA T5J 1Y6 CA
CEO: Terry Booth
Employees: 1101
Phone: 16043625207
AURORA CANNABIS INC / ACB FAQ
Can you describe the business of AURORA CANNABIS INC?
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
Can you provide the latest stock price for AURORA CANNABIS INC?
The current stock price of ACB is 4.54 USD. The price increased by 1.34% in the last trading session.
Does ACB stock pay dividends?
ACB does not pay a dividend.
How is the ChartMill rating for AURORA CANNABIS INC?
ACB has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the expected growth for ACB stock?
The Revenue of AURORA CANNABIS INC (ACB) is expected to grow by 8.72% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of ACB stock?
AURORA CANNABIS INC (ACB) has a market capitalization of 257.42M USD. This makes ACB a Micro Cap stock.
What is the ownership structure of AURORA CANNABIS INC (ACB)?
You can find the ownership structure of AURORA CANNABIS INC (ACB) on the Ownership tab.
ACB Technical Analysis
ACB Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ACB. ACB has a bad profitability rating. Also its financial health evaluation is rather negative.
ACB Financial Highlights
Over the last trailing twelve months ACB reported a non-GAAP Earnings per Share(EPS) of -0.26. The EPS increased by 57.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.78% | ||
| ROE | -11.07% | ||
| Debt/Equity | 0.07 |
ACB Forecast & Estimates
9 analysts have analysed ACB and the average price target is 5.77 USD. This implies a price increase of 27.05% is expected in the next year compared to the current price of 4.54.
For the next year, analysts expect an EPS growth of -288.53% and a revenue growth 8.72% for ACB